Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moroni

Showing results (271-280 of 332) with videos related to

Pageof 34
Sort By:
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1986
Persistent generalized lymphadenopathy in drug addicts: immunological studiesW Barcellini, P L Meroni, A Lazzarin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2001
Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimenA d' Arminio Monforte, F Adorni, L Meroni, et al.
Journal of Neurology|January 1, 1997
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patientsA d'Arminio Monforte, P Cinque, L Vago, et al.
The Journal of Infectious Diseases|May 1, 1997
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive personsM Clerici, S Piconi, C Balotta, et al.
Pathologica|January 1, 1986
[Pathology of HTLV III/LAV virus infection]L Vago, C L Parravicini, C M Antonacci, et al.
Journal of Virology|August 8, 1998
Human T-lymphotropic virus type 2 (HTLV-2) provirus in circulating cells of the monocyte/macrophage lineage in patients dually infected with human immunodeficiency virus type 1 and HTLV-2 and having predominantly sensory polyneuropathyG Zehender, L Meroni, S Varchetta, et al.
AIDS (London, England)|July 14, 2000
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategyS Menzo, S Rusconi, A Monachetti, et al.
American Journal of Epidemiology|February 1, 1986
Demonstration of antibodies to human T-lymphotropic retrovirus type III in lymphoadenopathy syndrome patients and in individuals at risk for acquired immune deficiency syndrome (AIDS) in ItalyM C Sirianni, P Rossi, M Moroni, et al.
Journal of Biological Regulators and Homeostatic Agents|November 6, 2001
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individualsR Mazzucchelli, S Corvasce, M Violin, et al.
Antiviral Therapy|December 1, 1996
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected peopleS Rusconi, M P De Pasquale, F Mainini, et al.
Pageof 34

Showing results (271-280 of 332) with videos related to

Sort By:
Pageof 34
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1986
Persistent generalized lymphadenopathy in drug addicts: immunological studiesW Barcellini, P L Meroni, A Lazzarin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2001
Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimenA d' Arminio Monforte, F Adorni, L Meroni, et al.
Journal of Neurology|January 1, 1997
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patientsA d'Arminio Monforte, P Cinque, L Vago, et al.
The Journal of Infectious Diseases|May 1, 1997
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive personsM Clerici, S Piconi, C Balotta, et al.
Pathologica|January 1, 1986
[Pathology of HTLV III/LAV virus infection]L Vago, C L Parravicini, C M Antonacci, et al.
Journal of Virology|August 8, 1998
Human T-lymphotropic virus type 2 (HTLV-2) provirus in circulating cells of the monocyte/macrophage lineage in patients dually infected with human immunodeficiency virus type 1 and HTLV-2 and having predominantly sensory polyneuropathyG Zehender, L Meroni, S Varchetta, et al.
AIDS (London, England)|July 14, 2000
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategyS Menzo, S Rusconi, A Monachetti, et al.
American Journal of Epidemiology|February 1, 1986
Demonstration of antibodies to human T-lymphotropic retrovirus type III in lymphoadenopathy syndrome patients and in individuals at risk for acquired immune deficiency syndrome (AIDS) in ItalyM C Sirianni, P Rossi, M Moroni, et al.
Journal of Biological Regulators and Homeostatic Agents|November 6, 2001
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individualsR Mazzucchelli, S Corvasce, M Violin, et al.
Antiviral Therapy|December 1, 1996
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected peopleS Rusconi, M P De Pasquale, F Mainini, et al.
Pageof 34